Here’s What AstraZeneca’s CEO Has to Say About the Weight Loss Drugs Market
- Stock Market Stocks to buy Stocks to sell
admin
- 0
- 1 minute read
Industry insiders often have perspectives that are invaluable for investors to learn. In that vein, AstraZeneca’s (NASDAQ: AZN) CEO, Pascal Soriot, recently made some interesting remarks during the company’s second-quarter earnings call with analysts.
:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-184827885-2--573b86c35f9b58723dbe24fa.jpg "<div>IPO vs. Staying Private: What's the Difference?</div>")
:max_bytes(150000):strip_icc():format(jpeg)/savingsvscdnews-98809008e8464a429fd41d4c5a32dd38.jpg "What Metrics Can Be Used to Evaluate Companies in the Financial Services Sector?")